anthony paul conley
University of Texas MD Anderson Cancer Center
Houston, United States
Associate Editor
Cancer Immunity and Immunotherapy
University of Texas MD Anderson Cancer Center
Houston, United States
Associate Editor
Cancer Immunity and Immunotherapy
Clinical Center (NIH)
Bethesda, United States
Associate Editor
Cancer Immunity and Immunotherapy
University of Santiago de Compostela
Santiago de Compostela, Spain
Associate Editor
Cancer Immunity and Immunotherapy
Institut National de la Santé et de la Recherche Médicale (INSERM)
Paris, France
Associate Editor
Cancer Immunity and Immunotherapy
Sorbonne Universités
Paris, France
Associate Editor
Cancer Immunity and Immunotherapy
INSERM UMR1236 Microenvironnement, Différenciation cellulaire, Immunologie et Cancer
Rennes, France
Associate Editor
Cancer Immunity and Immunotherapy
University of Bologna
Bologna, Italy
Associate Editor
Cancer Immunity and Immunotherapy
Moffitt Cancer Center
Tampa, United States
Associate Editor
Cancer Immunity and Immunotherapy
Speransa Therapeutics GmbH
Frankfurt, Germany
Associate Editor
Cancer Immunity and Immunotherapy
Medical Research Council Centre for Drug Safety Science, Department of Molecular and Clinical Pharmacology, Institute of Translational Medicine, University of liverpool
Liverpool, United Kingdom
Associate Editor
Cancer Immunity and Immunotherapy
University of Texas MD Anderson Cancer Center
Houston, United States
Associate Editor
Cancer Immunity and Immunotherapy
Jilin University
Changchun, China
Associate Editor
Cancer Immunity and Immunotherapy
Moffitt Cancer Center
Tampa, United States
Associate Editor
Cancer Immunity and Immunotherapy
University of Navarra
Pamplona, Spain
Associate Editor
Cancer Immunity and Immunotherapy
University Medical Center Groningen
Groningen, Netherlands
Associate Editor
Cancer Immunity and Immunotherapy
Baylor College of Medicine
Houston, United States
Associate Editor
Cancer Immunity and Immunotherapy